Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H22ClN3O |
Molecular Weight | 355.861 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC1=CC(NC2=CC=NC3=C2C=CC(Cl)=C3)=CC=C1O
InChI
InChIKey=OVCDSSHSILBFBN-UHFFFAOYSA-N
InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)
Molecular Formula | C20H22ClN3O |
Molecular Weight | 355.861 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:18 UTC 2023
by
admin
on
Fri Dec 15 14:59:18 UTC 2023
|
Record UNII |
220236ED28
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.3.1
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
||
|
LIVERTOX |
NBK548404
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
||
|
WHO-ATC |
P01BA06
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.3.1 (ART/AMO)
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
||
|
WHO-ATC |
P01BF03
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D000655
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
201-669-3
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
2674
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
SUB05470MIG
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
13453
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
AMODIAQUINE
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | Description: A yellow, crystalline powder; odourless. Solubility: Practically insoluble in water. Category: Antimalarial drug. Storage: Amodiaquine should be kept in a tightly closed container. Definition: Amodiaquine contains not less than 97.0% and not more than 103.0% of C20H22ClN3O, calculated with reference to the anhydrous substance. | ||
|
2165
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
DB00613
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL682
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
220236ED28
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
C65231
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
DTXSID2022597
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
100000089876
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
186
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
720
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
1116
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
7457
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
m1839
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
AMODIAQUINE
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY | |||
|
86-42-0
Created by
admin on Fri Dec 15 14:59:18 UTC 2023 , Edited by admin on Fri Dec 15 14:59:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
Activity dependent on strain
EC50
|
||
|
OFF-TARGET->INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
Some consider AMODIAQUINE to be a prodrug.
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|